HM10760A

erythropoietin (long-acting) · Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HM10760A, covering 2014-02-07 to 2014-02-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects [Phase 1]